MATEON’S UPDATE ON C001 – GLOBAL STUDY FOR OT-101 AGAINST COVID-19

NEXT STORY
OpGen Announces Publication of Final Study Results of Unyvero HPN Panel for Diagnosis of Bacterial Co-Infections in ICU Patients with COVID-19 Pneumonia
PREV STORY
Insights on the Nephrology Devices Global Market to 2025 – Impact of COVID-19 with Ansoff Analysis
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Multiverse Investment Fund Announces Portfolio Company’s Commencement of Clinical Trials to Treat Acute Respiratory Distress Syndrome (ARDS) Caused by Coronavirus (COVID-19)

author_avatar
NASDAQ Market News

Nestlé Health Science expands distribution of hemp products formulated with VESIsorb® into Europe under industry-leading brand, Pure Encapsulations®

author_avatar
NASDAQ Market News

Cyclacel Pharmaceuticals Announces That Full Results From the Phase 3 Seamless Trial Have Been Selected for Oral Presentation at ASH 2017 Annual Meeting

BERKELEY HEIGHTS, N.J., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) ...

author_avatar
NASDAQ Market News